Combination Immunotherapy Approaches in Metastatic Renal Cell Carcinoma with Favorable Risk Scores: A Meta-Analysis of Individual Patient Data - Poll - MDSpire

Combination Immunotherapy Approaches in Metastatic Renal Cell Carcinoma with Favorable Risk Scores: A Meta-Analysis of Individual Patient Data

  • By

  • Mattia Alberto Di Civita

  • Daniele Marinelli

  • Valerio Marco Michetti

  • Adele Artemi

  • Andrea Ballario

  • Andrea Torchia

  • Laura Pappalardo

  • Martina Pecoraro

  • Iolanda Speranza

  • Alessandro Sciarra

  • Valeria Panebianco

  • Michela Roberto

  • Daniele Santini

  • January 8, 2026

  • 0 min

Share

Original Source(s)

Combination Immunotherapy Approaches in Metastatic Renal Cell Carcinoma with Favorable Risk Scores: A Meta-Analysis of Individual Patient Data

  • by Mattia Alberto Di Civita, Daniele Marinelli, Valerio Marco Michetti, Adele Artemi, Andrea Ballario, Andrea Torchia, Laura Pappalardo, Martina Pecoraro, Iolanda Speranza, Alessandro Sciarra, Valeria Panebianco, Michela Roberto, Daniele Santini

  • January 8, 2026

Related Content

Rethinking the evidence for intensive surveillance after renal tumor ablation

Factors Influencing the Severity of Pneumonitis Associated with Immune Checkpoint Inhibitors: Insights from Clinical, Radiological, and Laboratory Data in Real-World Settings

Molecular Profiling, Prognostic Insights, and Immune Landscape Evaluation of NUDT16 in Clear Cell Renal Cell Carcinoma